Decarboxylase inhibitor, Carbidopa, Purity ≥98%

Synonym: 28860-95-9; Lodosyn; S-(-)-Carbidopa; (S)-carbidopa; Carbidopa anhydrous; (S)-(-)-carbidopa; ɑ-Methyldopahydrazine; L-ɑ-Methyldopahydrazine; N-Aminomethyldopa; Carbidopum; (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid; Decarboxylase inhibitor

MDL: MFCD00069231
CAS Number: 28860-95-9
Compound CID: 34359

Product Size

25 mg; 50 mg; 100 mg; 200 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Carbidopa, soluble in DMSO and insoluble in water and ethanol, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting decarboxylase. The molecular weight of the compound is 226.2, and its molecular formula is C₁₀H₁₄N₂O₄.

Molecular Weight

226.2

Molecular Formula

C₁₀H₁₄N₂O₄

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 3 mg/mL (13.26 mM); Water: insoluble; Ethanol: insoluble; In vivo: 4% DMSO + 30% PEG 300 + 2% Tween 80 + ddH₂O, 1 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

Carbidopa can be studied extensively for its potential therapeutic applications in the treatment of Parkinson’s disease, improving motor function and reducing symptoms.